741814471	741814471	CD	B-NP	O
|	|	NN	I-NP	O
OMGH	OMGH	NN	I-NP	O
|	|	NN	I-NP	O
24243765	24243765	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9098249	9098249	CD	B-NP	O
|	|	CC	I-NP	O
5/10/2006	5/10/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
non-cardiac	non-cardiac	JJ	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/3/2006	11/3/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/4/2006	11/4/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
STENBACK	STENBACK	NNP	B-NP	O
,	,	,	O	O
IVAN	IVAN	NNP	B-NP	O
789-27-33-6	789-27-33-6	NNP	I-NP	O
Ton	Ton	NNP	I-NP	O
Che	Che	NNP	I-NP	O
Ster	Ster	NNP	I-NP	O
,	,	,	O	O
CT	CT	NNP	B-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
3/26/06	3/26/06	CD	B-NP	O
AT	AT	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
NIDIFFER	NIDIFFER	NNP	B-NP	O
,	,	,	O	O
PHIL	PHIL	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
January	January	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/10/06	10/10/06	CD	B-NP	O
by	by	IN	B-PP	O
CABRERO	CABRERO	NNP	B-NP	O
,	,	,	O	O
JULIUS	JULIUS	NNP	B-NP	O
KIM	KIM	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
747935475	747935475	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
IBUPROFEN	IBUPROFEN	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Hives	Hive	NNS	B-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
NORVASC	NORVASC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AMLODIPINE	AMLODIPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
January	January	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

LIPITOR	LIPITOR	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
January	January	NNP	I-NP	O
CANDESARTAN	CANDESARTAN	NNP	I-NP	O
32	32	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/10/06	10/10/06	CD	B-NP	O
by	by	IN	B-PP	O
FENOFF	FENOFF	NNP	B-NP	O
,	,	,	O	O
LUCAS	LUCAS	NNP	B-NP	O
D	D	NNP	I-NP	O
DOMINICK	DOMINICK	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IMMED	IMMED	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O

PO	PO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
897985370	897985370	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CANDESARTAN	CANDESARTAN	NNP	B-NP	O
CILEXETIL	CILEXETIL	NNP	I-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	B-DNA
PLAVIX	PLAVIX	NN	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	I-DNA
-RRB-	-RRB-	HYPH	O	I-DNA
75	75	CD	B-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
DAILY	DAILY	NNP	I-NP	I-DNA
NEXIUM	NEXIUM	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
40	40	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
DAILY	DAILY	NNP	I-NP	I-DNA
ADVAIR	ADVAIR	NNP	I-NP	I-DNA
DISKUS	DISKUS	NNP	I-NP	I-DNA
250/50	250/50	CD	I-NP	I-DNA
-LRB-	-LRB-	HYPH	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
/	/	SYM	B-NP	O
...	...	:	O	B-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
PUFF	PUFF	NN	I-NP	I-protein
INH	INH	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
FOLATE	FOLATE	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
FOLIC	FOLIC	NN	I-NP	I-protein
ACID	ACID	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
DAILY	DAILY	NN	I-NP	I-protein
LASIX	LASIX	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
40	40	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/10/06	10/10/06	CD	B-NP	O
by	by	IN	B-PP	O
KOLLMAN	KOLLMAN	NNP	B-NP	O
,	,	,	O	O
DARYL	DARYL	NNP	B-NP	O
WAYNE	WAYNE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LASIX	LASIX	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
436834400	436834400	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
SULFA	SULFA	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
SULFONAMIDES	SULFONAMIDES	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Unknown	Unknown	JJ	B-ADJP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
LABETALOL	LABETALOL	NN	I-NP	O
HCL	HCL	NN	I-NP	O
200	200	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

LISINOPRIL	LISINOPRIL	NN	B-NP	B-protein
20	20	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/26/06	3/26/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MD	MD	NN	B-NP	O
aware	aware	JJ	I-NP	O
TOPROL	TOPROL	NN	I-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

NIFEREX-150	NIFEREX-150	NN	B-NP	B-protein
150	150	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
OXYCODONE	OXYCODONE	NNP	I-NP	I-protein
5-10	5-10	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Q4H	Q4H	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Pain	Pain	NNP	I-NP	I-protein
HOLD	HOLD	NNP	I-NP	I-protein
IF	IF	NNP	I-NP	I-protein
:	:	:	O	O
rr	rr	NN	B-NP	O
<	<	SYM	B-NP	O
10	10	CD	I-NP	O
,	,	,	O	O
overly	overly	RB	B-VP	O
sedated	sedate	VBD	I-VP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/16/06	11/16/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
OXYCODONE	OXYCODONE	NN	B-NP	O
PO	PO	NN	I-NP	O
5-10	5-10	CD	I-NP	O
MG	MG	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
785511528	785511528	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-VP	O
MORPHINE	MORPHINE	VB	I-VP	O
CONTROLLED	CONTROLLED	VBN	B-NP	O
RELEASE	RELEASE	NN	I-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
nausea	nausea	NN	B-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	VB	B-VP	O
on	on	RP	B-PRT	O
as	as	IN	B-PP	O
outpt	outpt	JJ	B-NP	O
Previous	Previous	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/10/06	10/10/06	CD	B-NP	O
by	by	IN	B-PP	O
BINGMAN	BINGMAN	NNP	B-NP	O
,	,	,	O	O
JOHN	JOHN	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
OXYCODONE	OXYCODONE	NN	B-NP	O
PO	PO	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
698187414	698187414	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-VP	O
MORPHINE	MORPHINE	VB	I-VP	O
CONTROLLED	CONTROLLED	VBN	B-NP	O
RELEASE	RELEASE	NN	I-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
nausea	nausea	NN	B-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ok	ok	VB	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
reason	reason	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/10/06	10/10/06	CD	B-NP	O
by	by	IN	B-PP	O
VANWYCK	VANWYCK	NNP	B-NP	O
,	,	,	O	O
TERENCE	TERENCE	NNP	B-NP	O
ANTON	ANTON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
OXYCODONE	OXYCODONE	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
822580407	822580407	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-VP	O
MORPHINE	MORPHINE	VB	I-VP	O
CONTROLLED	CONTROLLED	VBN	B-NP	O
RELEASE	RELEASE	NN	I-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
nausea	nausea	NN	B-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
OXYCONTIN	OXYCONTIN	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OXYCODONE	OXYCODONE	NNP	I-NP	O
CONTROLLED	CONTROLLED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
January	January	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/10/06	10/10/06	CD	B-NP	O
by	by	IN	B-PP	O
MOORING	MOORING	NNP	B-NP	O
,	,	,	O	O
SYDNEY	SYDNEY	NNP	B-NP	O
ELLSWORTH	ELLSWORTH	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
OXYCONTIN	OXYCONTIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
819882672	819882672	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-VP	O
MORPHINE	MORPHINE	VB	I-VP	O
CONTROLLED	CONTROLLED	VBN	B-NP	O
RELEASE	RELEASE	NN	I-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
nausea	nausea	NN	B-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Edgar	Edgar	NNP	I-NP	O
Speidel	Speidel	NNP	I-NP	O
3/1/06	3/1/06	CD	I-NP	O
2	2	CD	I-NP	O
:	:	:	O	O
40	40	CD	B-NP	O
pm	pm	NN	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Erythromycins	Erythromycin	NNS	B-NP	O
,	,	,	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
CLINDAMYCIN	CLINDAMYCIN	NNP	B-NP	O
,	,	,	O	O
IBUPROFEN	IBUPROFEN	NNP	B-NP	O
,	,	,	O	O
MORPHINE	MORPHINE	NNP	B-NP	O
CONTROLLED	CONTROLLED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
,	,	,	O	O
SULFA	SULFA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SULFONAMIDES	SULFONAMIDES	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
chest	ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
non-cardiac	non-cardiac	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CAD	CAD	NNP	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
asthma	asthma	NN	B-NP	O
,	,	,	O	O
OSA	OSA	NN	B-NP	B-protein
,	,	,	O	O
obesity	obesity	NN	B-NP	O
h/o	h/o	NN	I-NP	O
IMI	IMI	NN	I-NP	O
Non-cardiac	Non-cardiac	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
Lumbosacral	Lumbosacral	JJ	I-NP	O
disc	disc	NN	I-NP	O
dz	dz	NN	I-NP	O
Chronic	Chronic	JJ	I-NP	O
pain	pain	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
Migraines	Migraine	VBZ	B-VP	O
HTN	HTN	NN	B-NP	O
Anxiety	Anxiety	NN	I-NP	O
Depression	Depression	NN	I-NP	O
ALLERG	ALLERG	NN	I-NP	O
:	:	:	O	O
PCN	PCN	NN	B-NP	B-protein
,	,	,	O	O
Erythro	Erythro	NNP	B-NP	O
,	,	,	O	O
Tetracy	Tetracy	NNP	B-NP	O
S/P	S/P	NNP	I-NP	O
PTCA	PTCA	NNP	I-NP	O
1/11	1/11	CD	I-NP	O
FOR	FOR	NNP	I-NP	O
OCC	OCC	NNP	I-NP	O
RCA	RCA	NNP	I-NP	O
POSITIVE	POSITIVE	NNP	I-NP	O
ETT/MIBI	ETT/MIBI	NNP	I-NP	O
93	93	CD	I-NP	O
:	:	:	O	O
ANT/LAT	ANT/LAT	NNP	B-NP	O
WALL	WALL	NNP	I-NP	O
ISCHEMIA	ISCHEMIA	NNP	I-NP	O
OPERATIONS	OPERATIONS	NNPS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNPS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
chest	ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
********************	********************	SYM	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
59	59	CD	B-NP	O
yo	yo	NN	I-NP	O
woman	woman	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
CAD	CAD	NN	I-NP	O
-LRB-	-LRB-	SYM	B-VP	O
PCI	PCI	NN	B-NP	O
9/19	9/19	CD	I-NP	O
OM1	OM1	NN	I-NP	O
,	,	,	O	O
RCA	RCA	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
OSA	OSA	NN	B-NP	B-protein
,	,	,	O	O
asthma	asthma	NN	B-NP	B-protein
p/w	p/w	NN	I-NP	I-protein
R	R	NN	I-NP	I-protein
sided	side	VBD	B-VP	I-protein
chest	chest	NN	B-NP	I-protein
pain	pain	NN	I-NP	I-protein
x	x	SYM	B-NP	I-protein
3	3	CD	B-NP	I-protein
days	day	NNS	I-NP	I-protein
-LRB-	-LRB-	JJ	B-NP	I-protein
constant	constant	JJ	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	B-NP	O
not	not	RB	I-NP	O
associated	associate	VBN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	O	O
exertion	exertion	NN	B-NP	O
radiating	radiate	VBG	B-VP	O
to	to	TO	B-PP	O
R	R	NN	B-NP	O
shoulder	shoulder	NN	I-NP	O
,	,	,	O	O
not	not	RB	B-VP	O
relieved	relieve	VBN	I-VP	O
with	with	IN	B-PP	O
nitroglycerin	nitroglycerin	NN	B-NP	B-protein
.	.	.	O	O

Also	Also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
increasing	increase	VBG	I-VP	O
SOB/nausea/vomiting	SOB/nausea/vomite	VBG	I-VP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
over	over	IN	B-PP	O
this	this	DT	B-NP	O
period	period	NN	I-NP	O
.	.	.	O	O

Took	Took	NN	B-NP	O
oxycodone/percocet	oxycodone/percocet	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
some	some	DT	B-NP	O
relief	relief	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-NP	O
c/o	c/o	NN	I-NP	O
HA	HA	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
fever/chills	fever/chill	NNS	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
over	over	IN	B-PP	O
past	past	JJ	B-NP	O
month	month	NN	I-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
flashes	flash	NNS	B-NP	O
of	of	IN	B-PP	O
light	light	NN	B-NP	O
and	and	CC	B-NP	O
then	then	RB	I-NP	O
vision	vision	NN	B-NP	O
goes	go	VBZ	B-VP	O
dark	dark	JJ	B-ADJP	O
in	in	IN	B-PP	O
R	R	NN	B-NP	O
eye	eye	NN	I-NP	O
,	,	,	B-NP	O
not	not	RB	I-NP	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
HA	HA	NN	B-NP	B-protein
.	.	.	O	O

********************	********************	SYM	O	O
Physical	Physical	JJ	B-NP	O
Exam	Exam	NN	I-NP	O
:	:	:	O	O
ED	ED	JJ	B-NP	B-DNA
BP	BP	NN	I-NP	I-DNA
198/109	198/109	CD	I-NP	I-DNA
--	--	:	O	O
>	>	SYM	O	O
120/78	120/78	CD	B-NP	O
;	;	:	O	O
HR	HR	NN	B-NP	O
60s-90s	60s-90	NNS	I-NP	O
;	;	:	O	O
O2sat	O2sat	NN	B-NP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
,	,	,	O	O
Lungs-clear	Lungs-clear	JJ	B-NP	O
,	,	,	I-NP	O
JVP	JVP	NN	I-NP	O
6cm	6cm	NN	I-NP	O
,	,	,	O	O
CV-RRR	CV-RRR	NN	B-NP	B-protein
S1S2	S1S2	NN	I-NP	I-protein
II/VI	II/VI	NN	I-NP	I-protein
systolic	systolic	JJ	I-NP	I-protein
murmur	murmur	NN	I-NP	I-protein
RUSB	RUSB	NN	I-NP	I-protein
,	,	,	O	O
Abd	Abd	NN	B-NP	B-protein
-	-	HYPH	O	O
+	+	SYM	B-NP	O
BS	BS	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
diffuse	diffuse	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
;	;	:	O	O
non-pitting	non-pitting	JJ	B-NP	O
edema	edema	NN	I-NP	O
b/l	b/l	NN	I-NP	O
;	;	:	O	O
good	good	JJ	B-NP	O
pulses	pulse	NNS	I-NP	O
********************	********************	SYM	B-NP	O
Studies	Study	NNS	I-NP	O
:	:	:	O	O
Cr	Cr	NN	B-NP	O
1.2	1.2	CD	I-NP	O
-LRB-	-LRB-	:	O	O
baseline	baseline	NN	B-NP	O
1.0-1	1.0-1	CD	B-NP	O
.8	.8	CD	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
Cardiac	Cardiac	JJ	I-NP	O
enzymes-A	enzymes-A	NN	I-NP	O
set	set	NN	I-NP	O
neg	neg	NN	I-NP	O
,	,	,	O	O
B	B	NN	B-NP	O
set	set	NN	I-NP	O
troponin	troponin	NN	I-NP	O
0.13	0.13	CD	I-NP	O
U/A	U/A	NNP	I-NP	O
-29	-29	CD	I-NP	O
WBC	WBC	NNP	I-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
squam	squam	NN	I-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
NSR	NSR	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
PACs	PAC	NNS	I-NP	B-cell_type
AT	AT	IN	B-PP	O
84	84	CD	B-NP	O
bpm	bpm	NN	I-NP	O
,	,	,	O	O
nml	nml	NN	B-NP	O
axis	axis	NN	I-NP	O
,	,	,	O	O
LVH	LVH	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
q	q	NN	I-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
ST	ST	JJ	I-NP	O
elev/depr	elev/depr	NN	I-NP	O
,	,	,	O	O
TWI	TWI	NN	B-NP	B-protein
I	I	PRP	B-NP	I-protein
-LRB-	-LRB-	VBP	B-VP	O
old	old	JJ	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
II	II	CD	B-NP	O
,	,	,	O	O
AVF	AVF	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
new	new	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein
,	,	,	O	O
V6	V6	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
new	new	JJ	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
pseudonormalization	pseudonormalization	NN	B-NP	O
AVL	AVL	NN	I-NP	O
CT	CT	NN	I-NP	O
dissection	dissection	NN	I-NP	O
protocol-negative	protocol-negative	JJ	I-NP	O
MRA	MRA	NN	I-NP	O
neck	neck	NN	I-NP	O
7/3/06	7/3/06	CD	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
vascular	vascular	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
occlusion	occlusion	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
aneurysmal	aneurysmal	JJ	B-NP	O
change	change	NN	I-NP	O
.	.	.	O	O

Mild	Mild	JJ	B-NP	O
tortuosity	tortuosity	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
internal	internal	JJ	I-NP	O
carotid	carotid	NN	I-NP	O
arteries	artery	NNS	I-NP	O
.	.	.	O	O

Echo	Echo	NNP	B-NP	O
1/18/06	1/18/06	CD	I-NP	O
:	:	:	O	O
Severe	Severe	JJ	B-NP	O
LVH	LVH	NN	I-NP	O
,	,	,	O	O
EF	EF	NN	B-NP	O
50-55	50-55	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
diastolic	diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
basal	basal	JJ	B-NP	O
inferior	inferior	JJ	I-NP	O
akinetic	akinetic	JJ	I-NP	O
,	,	,	I-NP	O
basal	basal	JJ	I-NP	O
superior	superior	JJ	I-NP	O
dyskinetic	dyskinetic	JJ	I-NP	O
,	,	,	I-NP	O
mid-posterior	mid-posterior	JJ	I-NP	O
hypokinetic	hypokinetic	JJ	I-NP	O
unchanged	unchanged	JJ	I-NP	O
from	from	IN	B-PP	O
prev	prev	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
PFO	PFO	NNP	I-NP	O
June	June	NNP	I-NP	O
clean	clean	JJ	I-NP	O
coronaries	coronary	NNS	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
stents	stent	NNS	I-NP	O
patent	patent	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
********************	********************	SYM	B-NP	O
Impression	Impression	NN	I-NP	O
and	and	CC	I-NP	O
Plan	Plan	NN	I-NP	O
:	:	:	O	O
59	59	CD	B-NP	O
yo	yo	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
diastolic	diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
OSA	OSA	NN	B-NP	B-protein
,	,	,	O	O
p/w	p/w	NN	B-NP	B-protein
hypertensive	hypertensive	JJ	I-NP	I-protein
emergency	emergency	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
BP	BP	NN	I-NP	I-protein
190s	190	NNS	I-NP	I-protein
in	in	IN	B-PP	O
ED	ED	NN	B-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
troponin	troponin	NN	I-NP	O
leak	leak	NN	I-NP	O
likely	likely	RB	B-ADJP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
increased	increase	VBN	B-NP	O
BPs	BP	NNS	I-NP	B-protein
and	and	CC	I-NP	O
demand	demand	NN	I-NP	O
.	.	.	O	O

Hospital	Hospital	NN	B-NP	O
Course	Course	NN	I-NP	O
by	by	IN	B-PP	O
System	System	NN	B-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
ED	ED	NN	B-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	O
was	be	VBD	B-VP	O
198/109	198/109	CD	B-NP	O
with	with	IN	B-PP	O
HR	HR	NN	B-NP	B-protein
98	98	CD	I-NP	I-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
received	receive	VBD	B-VP	O
given	give	VBN	I-VP	O
ASA	ASA	NNP	B-NP	O
325	325	CD	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NNP	B-NP	O
5mg	5mg	CD	I-NP	O
,	,	,	O	O
Morphine	Morphine	NNP	B-NP	O
2mg	2mg	NN	I-NP	O
,	,	,	O	O
Nitro	Nitro	NNP	B-NP	O
SL	SL	NNP	I-NP	O
,	,	,	O	O
Hydral	Hydral	NNP	B-NP	O
10mg	10mg	CD	I-NP	O
,	,	,	O	O
Dilaudid	Dilaudid	NNP	B-NP	O
.	.	.	O	O

BP	BP	NN	B-NP	O
decreased	decrease	VBD	B-VP	O
to	to	TO	B-PP	O
120/78	120/78	CD	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
new	new	JJ	B-NP	O
T	T	NN	I-NP	O
wave	wave	NN	I-NP	O
inversions	inversion	NNS	I-NP	O
in	in	IN	B-PP	O
AVF	AVF	NN	B-NP	B-protein
and	and	CC	I-NP	O
V6	V6	NN	I-NP	O
with	with	IN	B-PP	O
pseudonormalization	pseudonormalization	NN	B-NP	O
of	of	IN	B-PP	O
T	T	NN	B-NP	O
wave	wave	NN	I-NP	O
in	in	IN	B-PP	O
AVL	AVL	NN	B-NP	O
.	.	.	O	O

CT	CT	NN	B-NP	O
chest	chest	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
dissection	dissection	NN	B-NP	O
.	.	.	O	O

Serial	Serial	JJ	B-NP	O
troponins	troponin	NNS	I-NP	O
were	be	VBD	B-VP	O
<	<	SYM	B-NP	O
0.10	0.10	CD	I-NP	O
,	,	,	I-NP	O
0.13	0.13	CD	I-NP	O
,	,	,	O	O
<	<	JJR	B-NP	O
0.10	0.10	CD	I-NP	O
,	,	,	O	O
bump	bump	VB	B-VP	O
likely	likely	JJ	B-NP	O
result	result	NN	I-NP	O
of	of	IN	B-PP	O
demand	demand	NN	B-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
pt	pt	NN	B-NP	O
's	's	POS	B-NP	O
CP	CP	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
reproducible	reproducible	JJ	B-ADJP	O
on	on	IN	B-PP	O
palpation	palpation	NN	B-NP	O
,	,	,	B-ADJP	O
not	not	RB	I-ADJP	O
likely	likely	JJ	I-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
source	source	NN	I-NP	O
,	,	,	O	O
somewhat	somewhat	RB	B-VP	O
improved	improve	VBN	I-VP	O
with	with	IN	B-PP	O
narcotics	narcotic	NNS	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
maintained	maintain	VBD	B-VP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
regimen	regimen	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
BP	BP	NN	B-NP	O
control	control	NN	I-NP	O
from	from	IN	B-PP	O
120-160/60	120-160/60	CD	B-NP	O
-90	-90	CD	I-NP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
.	.	.	O	O

Echo	Echo	NNP	B-NP	O
showed	show	VBD	B-VP	O
severe	severe	JJ	B-NP	O
LVH	LVH	NN	I-NP	O
,	,	,	O	O
EF	EF	NN	B-NP	O
50-55	50-55	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
diastolic	diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
,	,	,	O	O
basal	basal	JJ	B-NP	O
inferior	inferior	JJ	I-NP	O
akinetic	akinetic	JJ	I-NP	O
,	,	,	I-NP	O
basal	basal	JJ	I-NP	O
superior	superior	JJ	I-NP	O
dyskinetic	dyskinetic	JJ	I-NP	O
,	,	,	I-NP	O
mid-posterior	mid-posterior	JJ	I-NP	O
hypokinetic	hypokinetic	JJ	I-NP	O
,	,	,	O	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
prev	prev	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Dodimead	Dodimead	NNP	I-NP	O
.	.	.	O	O

*	*	SYM	O	O
Neuro	Neuro	NN	B-NP	O
:	:	SYM	I-NP	O
Pt	Pt	NN	I-NP	O
described	describe	VBD	B-VP	O
HA	HA	NN	B-NP	O
and	and	CC	I-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
vision	vision	NN	B-NP	O
loss	loss	NN	I-NP	O
in	in	IN	B-PP	O
R	R	NN	B-NP	O
eye	eye	NN	I-NP	O
lasting	last	VBG	B-VP	O
5-10	5-10	CD	B-NP	O
minutes	minute	NNS	I-NP	O
,	,	,	O	O
concerning	concern	VBG	B-VP	O
for	for	IN	B-PP	O
amaurosis	amaurosis	NN	B-NP	O
fugax	fugax	NN	I-NP	O
vs	vs	IN	B-PP	O
atypical	atypical	JJ	B-NP	B-protein
migraine	migraine	NN	I-NP	I-protein
vs	vs	IN	B-PP	I-protein
temporal	temporal	JJ	B-NP	I-protein
arteritis	arteritis	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
biopsied	biopsie	VBN	I-VP	O
for	for	IN	B-PP	O
temporal	temporal	JJ	B-NP	O
arteritis	arteritis	NN	I-NP	O
in	in	IN	B-PP	O
10/5	10/5	CD	B-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
HA	HA	NN	B-NP	O
and	and	CC	O	O
elevated	elevate	VBN	B-NP	O
ESR	ESR	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
neg	neg	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Neuro	Neuro	NNP	B-NP	O
and	and	CC	I-NP	O
Ophtho	Ophtho	NNP	I-NP	O
consulted	consult	VBD	B-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
described	describe	VBD	B-VP	O
vision	vision	NN	B-NP	O
loss	loss	NN	I-NP	O
as	as	IN	B-PP	O
bilateral	bilateral	JJ	B-ADJP	O
to	to	TO	B-PP	O
consults	consult	NNS	B-NP	O
-	-	HYPH	O	O
less	less	RBR	B-VP	O
concerning	concern	VBG	I-VP	O
for	for	IN	B-PP	O
embolic	embolic	JJ	B-NP	O
event	event	NN	I-NP	O
.	.	.	O	O

MRA	MRA	NN	B-NP	B-protein
demonstrated	demonstrate	VBD	B-VP	O
no	no	DT	B-NP	O
carotid	carotid	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
or	or	CC	I-NP	O
occlusion	occlusion	NN	I-NP	O
.	.	.	O	O

ESR	ESR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
only	only	RB	B-ADJP	O
mildly	mildly	RB	I-ADJP	O
elevated	elevated	JJ	I-ADJP	O
at	at	IN	B-PP	O
32	32	CD	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
is	be	VBZ	B-VP	O
already	already	RB	B-ADVP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
and	and	CC	I-NP	O
BP	BP	NN	I-NP	O
meds	med	NNS	I-NP	O
for	for	IN	B-PP	O
stroke	stroke	NN	B-NP	O
prevention	prevention	NN	I-NP	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
Neuro	Neuro	NNP	B-NP	B-cell_type
recs	rec	NNS	I-NP	I-cell_type
,	,	,	O	O
though	though	IN	B-SBAR	O
they	they	PRP	B-NP	O
recommended	recommend	VBD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
Rheum	Rheum	NNP	I-NP	O
to	to	TO	B-VP	O
w/u	w/u	VB	I-VP	O
temporal	temporal	JJ	B-NP	O
arteritis	arteritis	NN	I-NP	O
if	if	IN	B-SBAR	O
sx	sx	NN	B-NP	O
continue	continue	VBP	B-VP	O
.	.	.	O	O

Ophtho	Ophtho	NN	B-NP	O
exam	exam	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
typical	typical	JJ	B-NP	O
dermoid	dermoid	NN	I-NP	O
in	in	IN	B-PP	O
L	L	NN	B-NP	O
eye	eye	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
unrelated	unrelated	JJ	B-ADJP	O
to	to	TO	B-PP	O
sx	sx	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
retinal	retinal	JJ	B-NP	O
exam	exam	NN	I-NP	O
showed	show	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
PVD	PVD	NN	B-NP	B-protein
but	but	CC	O	O
no	no	DT	B-NP	O
emboli	emboli	NN	I-NP	O
,	,	,	O	O
consult	consult	NN	B-NP	O
thought	think	VBD	B-VP	O
presentation	presentation	NN	B-NP	O
not	not	RB	B-ADJP	O
consistent	consistent	JJ	I-ADJP	O
with	with	IN	B-PP	O
giant	giant	JJ	B-NP	O
cell	cell	NN	I-NP	O
arteritis	arteritis	NN	I-NP	O
,	,	,	O	O
most	most	RBS	B-NP	O
likely	likely	JJ	I-NP	O
atypical	atypical	JJ	I-NP	O
migraine	migraine	NN	I-NP	O
.	.	.	O	O

*	*	SYM	B-NP	O
Pulm	Pulm	NN	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
maintained	maintain	VBN	B-VP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
Advair	Advair	NN	B-NP	O
for	for	IN	B-PP	O
asthma	asthma	NN	B-NP	O
and	and	CC	I-NP	O
CPAP	CPAP	NN	I-NP	B-protein
at	at	IN	B-PP	O
night	night	NN	B-NP	O
for	for	IN	B-PP	O
OSA	OSA	NNP	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
exacerbations	exacerbation	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

*	*	SYM	O	O
Renal	Renal	JJ	O	O
:	:	:	O	O
Cr	Cr	NN	B-NP	O
increased	increase	VBD	B-VP	O
from	from	IN	B-PP	O
1.2	1.2	CD	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
baseline	baseline	NN	I-NP	O
1.0-1	1.0-1	CD	I-NP	O
.8	.8	CD	I-NP	O
,	,	,	O	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
2/2	2/2	CD	B-NP	O
to	to	TO	B-PP	O
chronic	chronic	JJ	B-NP	O
HTN	HTN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
to	to	TO	B-PP	O
1.7	1.7	CD	B-NP	O
on	on	IN	B-PP	O
HD	HD	NN	B-NP	B-protein
#	#	#	B-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

Urine	Urine	NN	B-NP	O
lytes	lyte	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
Na	Na	NN	B-NP	B-protein
100	100	CD	I-NP	I-protein
Cl	Cl	NN	I-NP	I-protein
78	78	CD	B-NP	I-protein
Cr	Cr	NNP	I-NP	I-protein
152.3	152.3	CD	I-NP	I-protein
-LRB-	-LRB-	SYM	I-NP	O
FeNa	FeNa	NN	I-NP	O
0.56	0.56	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NNP	B-NP	O
,	,	,	O	O
UA	UA	NNP	B-NP	O
showed	show	VBD	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
LE	LE	NN	I-NP	O
.	.	.	O	O

10-15	10-15	CD	B-NP	O
WBC	WBC	NNP	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
bast6	bast6	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
sq	sq	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
not	not	RB	O	O
treated	treat	VBN	B-VP	O
because	because	IN	B-SBAR	O
pt	pt	NN	B-NP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
continue	continue	JJ	I-NP	O
home	home	NN	I-NP	O
medication	medication	NN	I-NP	O
regimen	regimen	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
increase	increase	VBP	B-VP	O
labetalol	labetalol	NN	B-NP	O
to	to	TO	B-PP	O
200	200	CD	B-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
norvasc	norvasc	NN	B-NP	O
to	to	TO	B-PP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
oxycontin	oxycontin	NN	B-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-PP	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
+	+	SYM	B-NP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
prescribed	prescribe	VBN	B-VP	O
in	in	IN	B-PP	O
hospital	hospital	NN	B-NP	O
-RRB-	-RRB-	SYM	B-NP	O
-	-	HYPH	I-NP	O
make	make	NN	I-NP	O
appointment	appointment	NN	I-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
primary	primary	JJ	B-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Edward	Edward	NNP	I-NP	O
R	R	NNP	I-NP	O
Freeland	Freeland	NNP	I-NP	O
-	-	HYPH	O	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
cardiologist	cardiologist	NN	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Krull	Krull	NNP	I-NP	O
on	on	IN	B-PP	O
5/10	5/10	CD	B-NP	O
at	at	IN	B-PP	O
2	2	CD	B-NP	O
:	:	:	O	O
40	40	CD	B-NP	O
pm	pm	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
his	his	PRP$	B-NP	O
office	office	NN	I-NP	O
will	will	MD	B-VP	O
call	call	VB	I-VP	O
you	you	PRP	B-NP	O
if	if	IN	B-SBAR	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
made	make	VBN	I-VP	O
earlier	earlier	RBR	B-ADVP	O
-RRB-	-RRB-	SYM	O	B-protein
-	-	HYPH	O	O
fluid	fluid	NN	B-NP	B-protein
restricted	restrict	VBN	B-VP	I-protein
-LRB-	-LRB-	NN	B-NP	I-protein
2	2	CD	I-NP	I-protein
L	L	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
and	and	CC	I-NP	O
salt	salt	NN	I-NP	O
restricted	restrict	VBD	B-VP	O
-LRB-	-LRB-	NN	B-NP	O
2	2	CD	I-NP	O
mg	mg	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
diet	diet	NN	I-NP	O
-	-	HYPH	B-NP	O
return	return	NN	I-NP	O
to	to	TO	B-PP	O
hospital	hospital	NN	B-NP	O
if	if	IN	B-SBAR	O
symptoms	symptom	NNS	B-NP	O
worsen	worsen	VBP	B-VP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Satisfactory	Satisfactory	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
continue	continue	JJ	I-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
increased	increase	VBD	B-VP	O
labetalol	labetalol	NN	B-NP	O
to	to	TO	B-PP	O
200	200	CD	B-NP	O
mg	mg	NN	I-NP	O
BID	BID	NN	I-NP	O
,	,	,	O	O
norvasc	norvasc	NN	B-NP	O
to	to	TO	B-PP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
BID	BID	NN	I-NP	O
,	,	,	O	O
oxycontin	oxycontin	NN	B-NP	O
dose	dose	NN	I-NP	O
from	from	IN	B-PP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
to	to	TO	B-PP	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
TID	TID	NN	I-NP	O
-	-	HYPH	B-NP	O
f/u	f/u	NN	I-NP	O
with	with	IN	B-PP	O
cardiologist	cardiologist	NN	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Kinzer	Kinzer	NNP	I-NP	O
-	-	:	O	O
f/u	f/u	NN	B-NP	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Abram	Abram	NNP	I-NP	O
Blazina	Blazina	NNP	I-NP	O
-	-	HYPH	B-NP	O
consider	consider	NN	I-NP	O
modification	modification	NN	I-NP	O
of	of	IN	B-PP	O
HTN	HTN	NN	B-NP	O
regimen	regimen	NN	I-NP	O
if	if	IN	B-SBAR	O
pressures	pressure	NNS	B-NP	O
not	not	RB	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
IRIGOYEN	IRIGOYEN	NNP	B-NP	O
,	,	,	O	O
RODOLFO	RODOLFO	NNP	B-NP	O
F.	F.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WR445	WR445	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
3/26/06	3/26/06	CD	I-NP	O
@	@	NN	I-NP	O
07	07	CD	I-NP	O
:	:	:	O	O
11	11	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

